Cytori Therapeutics Inc (CYTX) Stock Price, Forecast & Analysis
USA - NASDAQ:CYTX -
CYTX Key Statistics, Chart & Performance
The current stock price of CYTX is 0.2077 null. In the past month the price decreased by -18.55%. In the past year, price decreased by -69.9%.
CYTX Latest News, Press Relases and Analysis
About CYTX
Company Profile
Cytori Therapeutics, Inc. is discovering and developing proprietary cell-based therapeutics utilizing adult stem and regenerative cells derived from adipose tissue, also known as fat. The Company's preclinical investigational therapies target cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders, and new approaches for aesthetic and reconstructive surgery. To facilitate processing and delivery of adipose stem and regenerative cells, Cytori has developed its proprietary Celution System to isolate and concentrate a patient's own stem and regenerative cells in about an hour. This system will dramatically improve the speed in which personalized cell-based therapies can be delivered to patients.
Company Info
Cytori Therapeutics Inc
3020 CALLAN ROAD
SAN DIEGO CA 92121
CEO: Marc. H. Hedrick
Phone: 858-458-0900
Cytori Therapeutics Inc / CYTX FAQ
What does CYTX do?
Cytori Therapeutics, Inc. is discovering and developing proprietary cell-based therapeutics utilizing adult stem and regenerative cells derived from adipose tissue, also known as fat. The Company's preclinical investigational therapies target cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders, and new approaches for aesthetic and reconstructive surgery. To facilitate processing and delivery of adipose stem and regenerative cells, Cytori has developed its proprietary Celution System to isolate and concentrate a patient's own stem and regenerative cells in about an hour. This system will dramatically improve the speed in which personalized cell-based therapies can be delivered to patients.
Can you provide the latest stock price for Cytori Therapeutics Inc?
The current stock price of CYTX is 0.2077 null. The price decreased by -5.59% in the last trading session.
What is the dividend status of Cytori Therapeutics Inc?
CYTX does not pay a dividend.
How is the ChartMill rating for Cytori Therapeutics Inc?
CYTX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Would investing in Cytori Therapeutics Inc be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CYTX.
CYTX Technical Analysis
CYTX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CYTX. Both the profitability and financial health of CYTX have multiple concerns.
CYTX Financial Highlights
Over the last trailing twelve months CYTX reported a non-GAAP Earnings per Share(EPS) of -1.42. The EPS increased by 29.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -312.24% | ||
| ROA | -46.21% | ||
| ROE | -294.92% | ||
| Debt/Equity | 0.39 |